To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study.
Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms.
The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
All the news of the Institute of life sciences Frédéric Joliot
The "First international course on PET in Epilepsy", organized by the SHFJ in early June, brought together about thirty international specialists in the field. The challenge was to disseminate know-how widely developed at SHFJ: the pre-surgical localization of epileptic foci by PET in patients with focal drug-resistant epilepsies, candidates for resection neurosurgery.
Winfried Leibl (SB2SM) is a member of the steering committee of the MOMENTOM project (MOlecules and Materials for the ENergy of TOMorrow, IRS PARIS-SACLAY, 2017-2020) This project, funded within the framework of the Strategic Research Initiatives (IRS) of Paris-Saclay University, concerns molecules and materials for the energy of tomorrow.
Got it ! Thursday, the 18th of May 2017, at 9:30 pm, the 11.7 Tesla magnet of the Iseult project joined the CEA, after a journey started on the 4th of May in Belfort, to be installed at NeuroSpin.
After its creation by Michel Léonetti, a researcher at SPI / LERI, and Luc Boblet, external holder at the CEA, backed by the IDEX Paris-Saclay funding among other things, the H-Immune start-up recently signed a partnership agreement with the Pierre Fabre Innovation Fund to develop cancer immunotherapy treatments.
On Thursday, May 4, a giant magnet weighing 130 metric tons will leave the assembly plants in Belfort on its journey to the NeuroSpin research facility at the CEA's Paris-Saclay Center (Essonne).
The CEA Frédéric Joliot Institute is involved in project CARBAMAT to fight against antibiotic resistance. SATT Paris-Saclay, a company promoting technology transfer, supports this project.
On Tuesday 18 April 2017, CEA's Iseult project teams met in Belfort to celebrate the approach of their joint work.
From the 13th to the 17th of March, NeuroSpin has opened its doors to public and CEA agents, on the occasion of the 19th edition of the Brain Week. This year again, this event was a great success, thanks to quality conferences and perfectly orchestrated visits.
The paper collections located in the old documentation of Life Sciences (BioDoc, DRC building 530) were sorted, a part was kept and the rest was eliminated at the beginning of March so that the works on the new offices for the management of the Institute Frédéric Joliot can start.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.